A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
Clinical trial NCT03542175 · COMPLETED
Trial details
- NCT number
- NCT03542175
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2024-07-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.